Next Article in Journal
Diastereoselective Synthesis of Cyclopentanediols by InCl3/Al Mediated Intramolecular Pinacol Coupling Reaction in Aqueous Media
Next Article in Special Issue
Biosynthesis and Genetic Regulation of Proanthocyanidins in Plants
Previous Article in Journal
Surface-enhanced Raman Spectral Measurements of 5-Fluorouracil in Saliva
Previous Article in Special Issue
Evaluation of the Antioxidant Activity of Syzygium cumini Leaves
Article Menu

Export Article

Open AccessReview
Molecules 2008, 13(10), 2628-2651;

Anti-carcinogenic Effects of the Flavonoid Luteolin

Medical and Pharmaceutical Services, Berlin, Germany
Institute of Pharmaceutical Sciences, Department of Pharmaceutical Biology and Biotechnology, University of Freiburg, Germany
Competence center skintegral, Department of Dermatology, University Medical Center Freiburg, Germany
Author to whom correspondence should be addressed.
Received: 17 September 2008 / Revised: 17 October 2008 / Accepted: 21 October 2008 / Published: 22 October 2008
(This article belongs to the Special Issue Phenolics and Polyphenolics)
Full-Text   |   PDF [330 KB, uploaded 18 June 2014]   |  


Luteolin is a flavonoid which is part of our daily nutrition in relatively low amounts (less than 1 mg/day). Nevertheless, some epidemiological studies suggest an inverse correlation between luteolin intake and the risk of some cancer types. Luteolin displays specific anti-inflammatory and anti-carcinogenic effects, which can only partly be explained by its anti-oxidant and free radical scavenging capacities. Luteolin can delay or block the development of cancer cells in vitro and in vivo by protection from carcinogenic stimuli, by inhibition of tumor cell proliferation, by induction of cell cycle arrest and by induction of apoptosis via intrinsic and extrinsic signaling pathways. When compared to other flavonoids, luteolin was usually among the most effective ones, inhibiting tumor cell proliferation with IC50 values between 3 and 50 μM in vitro and in vivo by 5 to 10 mg/kg i.p., intragastric application of 0.1–0.3 mg/kg/d, or as food additive in concentrations of 50 to 200 ppm. Luteolin has been shown to penetrate into human skin, making it also a candidate for the prevention and treatment of skin cancer. View Full-Text
Keywords: Luteolin; Cancer; Pharmacology; Epidemiology Luteolin; Cancer; Pharmacology; Epidemiology

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Seelinger, G.; Merfort, I.; Wölfle, U.; Schempp, C.M. Anti-carcinogenic Effects of the Flavonoid Luteolin. Molecules 2008, 13, 2628-2651.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top